Shandong Keyuan Pharmaceutical Co., Ltd. reported earnings results for the nine months ended September 30, 2023. For the nine months, the company reported sales was CNY 340.68 million compared to CNY 334.44 million a year ago. Revenue was CNY 340.68 million compared to CNY 334.44 million a year ago.

Net income was CNY 66.55 million compared to CNY 68.87 million a year ago. Basic earnings per share from continuing operations was CNY 0.6705 compared to CNY 0.8481 a year ago. Diluted earnings per share from continuing operations was CNY 0.6705 compared to CNY 0.8481 a year ago.